Technologies related to NICHD

Custom text
Osmogels: A New Method for Stabilizing Weak Molecular Complex Interactions
Ref: NCI-E-214-2009 | Updated: 06/04/2021
Substrate Reduction Therapy for Smith-Lemli-Opitz Syndrome and Related Disorders
Ref: NCI-E-206-2007 | Updated: 06/04/2021
Improved Antibodies Against ERBB4/HER4
Ref: NCI-E-171-2009 | Updated: 06/04/2021
Diagnostic Assays for the Detection of Thyroid Cancer
Ref: NCI-E-016-2013 | Updated: 06/04/2021
CNS Therapeutics That Target Neuronal Ceroid-Lipofuscinoses and Thioesterase Deficiency Disorders
Ref: NCI-E-157-2011 | Updated: 06/04/2021
Cell Lines Expressing Nuclear and/or Mitochondrial RNAse H1
Ref: NCI-E-273-2012 | Updated: 06/04/2021
Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia (GSD-Ia)
Ref: NCI-E-039-2015 | Updated: 06/04/2021
Human Cell Line for Studies on Signaling and Endocrine Cancer
Ref: NCI-E-267-2012 | Updated: 06/04/2021
Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia (GSD-Ia)
Ref: E-039-2015 | Updated: 06/04/2021
Human Cell Line for Studies on Signaling and Endocrine Cancer
Ref: E-267-2012 | Updated: 06/04/2021
Cell Lines Expressing Nuclear and/or Mitochondrial RNAse H1
Ref: E-273-2012 | Updated: 06/04/2021
Osmogels: A New Method for Stabilizing Weak Molecular Complex Interactions
Ref: E-214-2009 | Updated: 06/04/2021
Substrate Reduction Therapy for Smith-Lemli-Opitz Syndrome and Related Disorders
Ref: E-206-2007 | Updated: 06/04/2021
Improved Antibodies Against ERBB4/HER4
Ref: E-171-2009 | Updated: 06/04/2021
Diagnostic Assays for the Detection of Thyroid Cancer
Ref: E-016-2013 | Updated: 06/04/2021
CNS Therapeutics That Target Neuronal Ceroid-Lipofuscinoses and Thioesterase Deficiency Disorders
Ref: E-157-2011 | Updated: 06/04/2021
Improved Gene Therapy Vectors for the Treatment of Glycogen Storage Disease Type Ia (GSD-1a)
Ref: E-552-2013 | Updated: 06/04/2021
Improved Gene Therapy Vectors for the Treatment of Glycogen Storage Disease Type Ia (GSD-1a)
Ref: NCI-E-552-2013 | Updated: 06/04/2021
Monomeric and Oligomeric Compounds as Contraceptives and Endocrine Therapeutics
Ref: E-141-2019 | Updated: 06/04/2021
Monomeric and Oligomeric Compounds as Contraceptives and Endocrine Therapeutics
Ref: NCI-E-141-2019 | Updated: 06/04/2021
Composite Gels and Methods of their Use in Tissue Repair, Drug Delivery, and as Implants
Ref: E-014-2019 | Updated: 06/04/2021
Composite Gels and Methods of their Use in Tissue Repair, Drug Delivery, and as Implants
Ref: NCI-E-014-2019 | Updated: 06/04/2021
Monoclonal Antibodies Against Bacillus Anthracis Antigens
Ref: TAB-3404 | Updated: 06/04/2021
Chimpanzee/Human Chimeric Monoclonal Antibodies That React With The Capsule Of Bacillus Anthracis And Kill The Organism By Opsonophagocytosis.
Ref: E-125-2008-0 | Updated: 06/08/2021
Assay for Predicting the Time of Onset of Niemann-Pick Disease Type C (NPC)
Ref: TAB-3415 | Updated: 06/04/2021
An Assay For Predicting The Time Of Onset Of Niemann-Pick Disease Type C (NPC)
Ref: E-060-2013-0 | Updated: 06/08/2021
Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer
Ref: E-138-2019 | Updated: 06/04/2021
Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer
Ref: NCI-E-138-2019 | Updated: 06/04/2021
A Novel Transgenic Zebrafish Line Reporting Dynamic Epigenetic Changes
Ref: E-124-2019 | Updated: 06/04/2021
A Novel Transgenic Zebrafish Line Reporting Dynamic Epigenetic Changes
Ref: NCI-E-124-2019 | Updated: 06/04/2021
Autophagy Modulators For Use in Treating Cancer
Ref: NCI-E-003-2018 | Updated: 06/04/2021
Monoclonal Antibody Fragments for Targeting Therapeutics to Growth Plate Cartilage
Ref: E-003-2014 | Updated: 06/04/2021
Autophagy Modulators For Use in Treating Cancer
Ref: E-003-2018 | Updated: 06/04/2021
Monoclonal Antibody Fragments for Targeting Therapeutics to Growth Plate Cartilage
Ref: NCI-E-003-2014 | Updated: 06/04/2021
Recombinant Virus Vectors for the Treatment of Glycogen Storage Disease type Ib (GSD-Ib)
Ref: E-072-2017 | Updated: 06/04/2021
Recombinant Virus Vectors for the Treatment of Glycogen Storage Disease type Ib (GSD-Ib)
Ref: NCI-E-072-2017 | Updated: 06/04/2021
Non-Invasive In Vivo MRI Method to Image Salient Features of Axons and Nerves
Ref: E-079-2003 | Updated: 06/04/2021
Non-Invasive In Vivo MRI Method to Image Salient Features of Axons and Nerves
Ref: NCI-E-079-2003 | Updated: 06/04/2021
Polarimetric Accessory for Colposcope
Ref: E-084-2012 | Updated: 06/04/2021
Polarimetric Accessory for Colposcope
Ref: NCI-E-084-2012 | Updated: 06/04/2021
Device for Simulating Explosive Blast and Imaging Biological Specimens
Ref: E-068-2012 | Updated: 06/04/2021
Device for Simulating Explosive Blast and Imaging Biological Specimens
Ref: NCI-E-068-2012 | Updated: 06/04/2021
Isotropic Generalized Diffusion Tensor MRI
Ref: E-093-2017 | Updated: 06/04/2021
Isotropic Generalized Diffusion Tensor MRI
Ref: NCI-E-093-2017 | Updated: 06/04/2021
CCR9 Knockout Mice
Ref: TAB-3280 | Updated: 06/04/2021
CCR9 Knockout Mice For Distribution By Jackson Laboratories
Ref: E-200-2015-0 | Updated: 06/08/2021
MADCO-Accelerated Multidimensional Diffusion MRI
Ref: E-173-2016 | Updated: 06/04/2021
MADCO-Accelerated Multidimensional Diffusion MRI
Ref: NCI-E-173-2016 | Updated: 06/04/2021
Quantitative In Vivo Methods for Measuring Brain Networks
Ref: E-226-2010 | Updated: 06/04/2021
Quantitative In Vivo Methods for Measuring Brain Networks
Ref: NCI-E-226-2010 | Updated: 06/04/2021
Treatment of GPR101-Related, Growth Hormone-Related Disorders Such as Gigantism, Dwarfism or Acromegaly
Ref: E-039-2016 | Updated: 06/04/2021
Treatment of GPR101-Related, Growth Hormone-Related Disorders Such as Gigantism, Dwarfism or Acromegaly
Ref: NCI-E-039-2016 | Updated: 06/04/2021
Predicting Age of Onset of Niemann-Pick Disease
Ref: TAB-2578 | Updated: 06/04/2021
Moraxella Catarrhalis Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections
Ref: TAB-2101 | Updated: 06/04/2021
LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF MORAXELLA (BRANHAMELLA) CATARHALIS INFECTIONS IN HUMANS
Ref: E-264-1997-0 | Updated: 06/08/2021
Monoclonal Antibodies That React With the Capsule of Bacillus anthracis
Ref: TAB-2006 | Updated: 06/04/2021
Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines
Ref: TAB-1707 | Updated: 06/04/2021
Creation of a Stable Recombinant Protective Antigen (rPA) Molecule By Deletions of the Chymotrypsin-Sensitive Loop and the Furin-Cleavage...
Ref: E-268-2002-0 | Updated: 06/04/2021
Method to Reduce the Bias in the Mean and Variance of Indices of Water Diffusion Anisotropy as Measured by Diffusion Tensor MRI
Ref: TAB-323 | Updated: 06/04/2021
Method to Significantly Reduce Bias and Variance of Diffusion Anisotropy Measurements
Ref: E-157-1996-0 | Updated: 06/08/2021
Subscribe to Technologies related to NICHD